List of Signals Notebook Customers
Revvity
77 4th Avenue,
Waltham, 2451, MA,
United States
Waltham, 2451, MA,
United States
1 781-663-6900
Professional Services
11000
$2.8B
Since 2010, our global team of researchers has been studying Signals Notebook customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Signals Notebook for Collaboration from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Signals Notebook for Collaboration include: AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Givaudan, a Switzerland based Manufacturing organisation with 16942 employees and revenues of $9.21 billion, Axxam, a Italy based Life Sciences organisation with 200 employees and revenues of $32.0 million and many others.
Contact us if you need a completed and verified list of companies using Signals Notebook, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Signals Notebook customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | Revvity | Signals Notebook | Collaboration | 2024 | n/a |
In 2024, AstraZeneca deployed Revvity Signals Notebook across its R&D organization to capture complex chemistry and biology experiments and to centralize experimental records. The deployment targeted the Collaboration category and was rolled out to over 3,800 scientists in about 18 months, covering global R&D with headquarters in the United Kingdom. This implementation emphasized standardized experiment capture and laboratory collaboration practices to improve data consistency across discovery teams.
The implementation of Revvity Signals Notebook included AI assisted experiment summarization capabilities to accelerate knowledge synthesis and reduce time spent on manual reporting. Configuration focused on structured experiment records and searchable metadata to support reuse of chemical and biological data. The Signals Notebook deployment functioned as the primary electronic lab notebook for experimental capture within impacted research groups.
Integrations were explicitly implemented with Signals ChemDraw and with custom inventory and analytics systems to improve data reuse, searchability, and downstream analytics. Those integrations linked molecular drawing and structure data from Signals ChemDraw into experiment records, and synchronized inventory and analytical metadata into the Signals Notebook repository to enable cross functional data discovery. The scope of integration extended across global R&D sites and research departments engaged in complex therapeutics development.
Governance and rollout emphasized rapid onboarding and change management to reach the stated user base in about 18 months, with centralized configuration of access controls, experiment versioning, and data retention policies to support research governance. The deployment enabled AI assisted experiment summarization to boost productivity and improved the findability and analytic readiness of experimental data for downstream workflows.
|
 |
Axxam | Life Sciences | 200 | $32M | Italy | Revvity | Signals Notebook | Collaboration | 2023 | n/a |
In 2023, Axxam transitioned from roughly 3,000 paper notebooks to Revvity Signals Notebook, adopting the Collaboration application to centralize experiment records across 13 experimental groups within its R&D and early discovery operations in Italy. The deployment targeted laboratory documentation standardization and traceability for early drug discovery workflows, bringing electronic experiment capture to site-level research teams.
The implementation used Revvity Signals Notebook APIs to migrate reagent and inventory data and to provision custom experiment templates and workflow logic. Signals Notebook was configured with structured experiment templates, embedded protocol workflows, and role-based access controls to enforce consistent metadata capture and experiment reproducibility. The migration workstreams included ingestion of reagent and inventory datasets via the application APIs, which supports inferred adoption of Samples and Inventory functionality for sample lifecycle and reagent tracking.
Operational coverage focused on R&D and early discovery teams across Axxam’s Italy sites, with adoption driven by 13 experimental groups that consolidated documentation into the single Collaboration platform. Integrations were executed through Signals Notebook APIs to bring reagent and inventory records into the system, creating integration points for laboratory sample tracking and experiment provenance without introducing new named external systems.
Governance changes emphasized standardized templates, enforced documentation workflows, and audit-capable records to strengthen data integrity and improve traceability. The rollout formalized experiment documentation standards across groups, and produced explicit outcomes of strengthened data integrity, standardized experiment documentation, and improved collaboration and traceability in early drug discovery.
|
 |
Givaudan | Manufacturing | 16942 | $9.2B | Switzerland | Revvity | Signals Notebook | Collaboration | 2021 | n/a |
In 2021, Givaudan deployed Revvity Signals Notebook across its global research labs to modernize chemical registration, material libraries, and inventory workflows. The Revvity Signals Notebook implementation was positioned as a Collaboration application supporting research and development functions with governance tied to the company headquarters in Switzerland.
The implementation configured module-level capabilities aligned to Samples and Inventory management and to Chemical Registration, using Signals Notebook to centralize material libraries, standardize registration workflows, and reduce manual handoffs. Configuration included structured chemical metadata capture, sample lifecycle tracking, and inventory transaction recording to support laboratory operations and reagent management.
Integrations were established with SAP for inventory and material synchronization and with PubChem for chemical metadata and reference data enrichment. The integration architecture connected Signals Notebook to enterprise inventory records and external chemical databases to ensure consistency of material information across research sites, enabling lookups and inventory reconciliation from within the notebook environment.
Rollout was executed globally across research sites with standardized workflows and centralized governance for registration and sample handling, accompanied by lab-level adoption planning and phased site enablement. Outcomes reported from the deployment included reduced manual steps in registration and inventory processes and improved accuracy of material and inventory data.
|
Showing 1 to 3 of 3 entries
Buyer Intent: Companies Evaluating Signals Notebook
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Signals Notebook. Gain ongoing access to real-time prospects and uncover hidden opportunities.
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD Signals Notebook Coverage
Signals Notebook is a Collaboration solution from Revvity.
Companies worldwide use Signals Notebook, from small firms to large enterprises across 21+ industries.
Organizations such as AstraZeneca, Givaudan and Axxam are recorded users of
Signals Notebook for Collaboration.
Companies using Signals Notebook are most concentrated in Life Sciences and Manufacturing, with adoption spanning over 21 industries.
Companies using Signals Notebook are most concentrated in United Kingdom, Switzerland and Italy, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Signals Notebook across Americas, EMEA, and APAC.
Companies using Signals Notebook range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 66.67%.
Customers of Signals Notebook include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Signals Notebook customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Collaboration.